Consolidated Statements of Operations (USD $)	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
REVENUES
Lab revenue	$ 2,912,129	$ 2,286,956
License revenue	22,469	42,709
Total Revenues	2,934,598	2,329,665
COST OF SALES	1,367,861	1,091,585
GROSS PROFIT	1,566,737	1,238,080
OPERATING EXPENSES
Salaries and wages	1,064,356	1,221,611
Depreciation and amortization expense	18,715	137,989
Impairment of long lived assets		119,603
Impairment of goodwill		202,688
General and administrative expenses	922,243	1,232,229
Total Operating Expenses	2,005,314	2,914,120
OPERATING LOSS	(438,577)	(1,676,040)
OTHER INCOME AND (EXPENSES)
Interest income		128
Interest expense	(156,925)	(274,114)
Other income	5,894	50,746
Other expense	5,551	(67,246)
Other expense - derivative	(78,408)
Total Other Income and Expenses	(223,888)	(290,486)
NET LOSS	(662,465)	(1,966,526)
Foreign currency translation	(9,100)	(8,866)
NET COMPREHENSIVE LOSS	(671,565)	(1,975,392)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (671,565)	$ (1,975,392)
Loss per Share Basic and Diluted	$ (0.01)	$ (0.05)
Weighted Average Number of Shares Outstanding, Basic and Diluted	47,264,151	43,588,970